Thursday was a historically strange day in the stock market. That may be good news

Thursday was a historically strange day in the stock market. That may be good news


Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 24, 2024. 

Brendan McDermid | Reuters

Wall Street saw a dramatic shift in market trends on Thursday, with winning and losing stocks swapping places for a day. It may turn out to be just what the rally needs to keep going.

The Russell 2000 small-cap index, which has struggled to find its footing all year, jumped more than 3% on Thursday. At the same time, every stock in the so-called “Magnficient 7” fell, including a nearly 5% decline for Nvidia and a 2% drop for Apple, which dragged down both the S&P 500 and Nasdaq Composite.

Bespoke Investment Group shared two statistics on the social media site X to demonstrate how rare it is to have that type of split.

  • Thursday was just the second day since 1979 when the Russell 2000 rose more than 3% while the S&P 500 declined.
  • The Nasdaq Composite was underperforming the Russell 2000 by 4.9 percentage points, the second-biggest daily gap on record. The other time came in November 2020, right after Pfizer shared positive results from a Covid-19 vaccine trial.

And while the major market averages and many individual 401k accounts may show a decline for the day, this odd set of results could be a positive sign for the market. Much of the recent rally has been driven by large tech companies, leading investment pros to worry about a narrow group of stock market leaders.

“Today’s an important day,” Ed Yardeni of Yardeni Research said on CNBC’s “Closing Bell. “This is the day where investors are starting to rotate out of the Magnificent 7 into the rest of the market. I don’t think this is going to continue to pull the S&P 500 down — I think there’s going to be enough money to keep the leading stocks that have done so well fairly elevated, but I think we are going to see more gains in the S&P 493, as well as in the small and mid-cap stocks,” he added.

The split trading came after the June report for the consumer price index early Thursday showed headline inflation declined last month and is now up about 3% over the past year. That bolstered confidence that the Federal Reserve will begin to cut interest rates as soon as September. Fed Chair Jerome Powell indicated in Congressional testimony this week that the central bank was aware that holding rates high for too long could hurt the economy.

The rate cut feels like it's really coming, says Ed Yardeni

“Investors are rotating: They’re jumping from the large-cap tech lily pad on to the mid- and small-cap pads, along with real estate,” said Sam Stovall, chief investment strategist at CFRA Research, told CNBC. “They had been waiting for maybe not a guarantee, but certainly a confirmation that the Fed is likely to start to cut interest rates, and will be doing so not in reaction to a recession.”

Activity in the bond market supports this idea. Yields on U.S. Treasurys were down across the board on Thursday, meaning government bond prices were rallying.

“You’ve got positive CPI on the back of a slightly dovish Powell,” Ross Mayfield, investment strategy analyst at Baird, told CNBC. “Rates are down big, and you have kind of a rotation trade. But the problem with the market being so concentrated in big tech is that that rotation trade can look like a surface level negative. And I think we’re seeing some of that today,” he said.

To be sure, there have also been signs in recent months that the U.S. economy is softening. A slow growth or recessionary environment would be tough for small cap stocks, which tend to be more economically sensitive and domestically-oriented than larger companies.

— CNBC’s Sarah Min and Alex Harring contributed reporting



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More